✦ LIBER ✦

P02-05 Comparison of brain morphology in Alzheimer’s dementia in the general population and demented subjects with Down’s syndrome

✍ Scribed by D. Mullins; E. Daly; A. Simmons; P. Johnston; K. Murphy; S. Lovestone; D. Murphy

Book ID: 119569456
Publisher: Elsevier Science
Year: 2009
Tongue: French
Weight: 44 KB
Volume: 24
Category: Article
ISSN: 0924-9338
DOI: 10.1016/s0924-9338(09)70928-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dementia in Down’s syndrome: an MRI comp

Dementia in Down’s syndrome: an MRI comparison with Alzheimer’s disease in the general population

✍ Mullins, Diane; Daly, Eileen; Simmons, Andrew; Beacher, Felix; Foy, Catherine ML 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 406 KB

P2-008 β-Amyloid accumulation and tau ph

P2-008 β-Amyloid accumulation and tau phosphorylation in the aged cat brain: comparison with Alzheimer's disease and Down syndrome

✍ Elizabeth Head; Kelly Moffatt; Pritam Das; Floyd Sarsoza; Gary M. Landsberg; Ira 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Variants in the CYP17 Cytochrome P450 ge

Variants in the CYP17 Cytochrome P450 gene are associated with dementia onset and risk of Alzheimer's disease in women with Down syndrome

✍ Joseph H. Lee; Constance Chace; Rong Cheng; Deborah Pang; Catherine Cheng; Kyung 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Review of donepezil, rivastigmine, galan

Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population

✍ V. P. Prasher 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Abstract The management of dementia in Alzheimer's disease has dramatically changed since the development of anti‐dementia drugs. However, there is limited information available regarding the bio‐medical aspects of the differing drugs; particularly relating to adults with intellectual disability